A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease
NCT02452723
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
BIOLOGICAL:
ISC-hpNSC
Sponsor
Cyto Therapeutics Pty Limited